Early Detection of Lung Tumors by Sniffer Dogs - Evaluation of Sensitivity and Specificity

NCT ID: NCT01141842

Last Updated: 2013-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

230 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-11-30

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Some groups reported that sniffer dogs can be applied to detect lung cancer in the exhaled breath of patients. Therefore, breath samples (BS) of patients are collected. Five sniffer dogs are trained to distinguish between the BS of patients with lung cancer and healthy individuals (controls). In a prospective, randomized blinded study the dog's ability to differentiate between BS of i) patients with lung cancer, ii) patients with inflammatory airway disease, but no evidence of cancer and iii) healthy individuals is tested.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All breath samples (BS) are collected in patients on the basis of radiologic findings before any intervention (bronchoscopy, biopsy or surgery) has been performed. The allocation to study groups is made following diagnostic work up and surgery.

Three study groups are defined using the following inclusion and exclusion criteria:

* lung cancer: male \& female, age 18-80, competent, confirmed lung cancer in diagnostic work up and surgery, no history or present other tumor disease
* healthy individual: male \& female, age 18-80, competent, no history or present other tumor disease including lung cancer, no pathological lung function tests
* chronic obstructive lung disease: male \& female, age 18-80, competent, no history or present other tumor disease including lung cancer, pathological lung function tests

For each patient, i) history, ii) present medication, iii) lung function tests are documented. For the lung cancer patients, the tumor stage following surgery is documented.

Five sniffer dogs are trained using BS of lung cancer patients and healthy individuals. After completion of the training the ability of the dogs to differentiate between the groups is tested:

* 5 BS are presented in 1 experiment:

* Test I: lung cancer vs healthy individual
* Test II: lung cancer vs chronic obstructive pulmonary disease
* Test III: lung cancer vs healthy individuals \& bronchitis
* for every experiment 1 BS of a lung cancer patient is used

* the lung cancer sample is placed randomly in one of the five test tubes
* the other test tubes are used for BS of healthy individuals or chronic obstructive pulmonary disease patients or both
* neither the dog handler nor the dog know the loading of the test tubes
* experiments are repeated 5 to 10 times

For analysis, the sensitivity and specificity of the dog's reaction is determined.

The patient's medication, smoking habits, age and gender are analysed to rule out confounders or bias.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Chronic Obstructive Airway Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

DOUBLE

Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lung cancer

breath samples of patients with confirmed lung cancer

Group Type EXPERIMENTAL

exhalation analysis of breath sample

Intervention Type PROCEDURE

breath sample is presented to sniffer dog in test tube

underlying lung disease

patients with underlying lung disease and impairment in lung function

Group Type ACTIVE_COMPARATOR

exhalation analysis of breath sample

Intervention Type PROCEDURE

breath sample is presented to sniffer dog in test tube

healthy individual

healthy individual with no lung disease and no history of cancer including lung cancer

Group Type SHAM_COMPARATOR

exhalation analysis of breath sample

Intervention Type PROCEDURE

breath sample is presented to sniffer dog in test tube

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

exhalation analysis of breath sample

breath sample is presented to sniffer dog in test tube

Intervention Type PROCEDURE

exhalation analysis of breath sample

breath sample is presented to sniffer dog in test tube

Intervention Type PROCEDURE

exhalation analysis of breath sample

breath sample is presented to sniffer dog in test tube

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-80
* competent
* confirmed lung cancer

Exclusion Criteria

* history of other cancers
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Schillerhoehe Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Thorsten Walles

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thorsten Walles, MD

Role: PRINCIPAL_INVESTIGATOR

Schillerhoehe Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Schillerhoehe Hospital

Gerlingen, , Germany

Site Status

Praxis Heimann & Ehmann

Stuttgart, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Boedeker E, Friedel G, Walles T. Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening. Interact Cardiovasc Thorac Surg. 2012 May;14(5):511-5. doi: 10.1093/icvts/ivr070. Epub 2012 Feb 17.

Reference Type BACKGROUND
PMID: 22345057 (View on PubMed)

Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G, Walles T. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J. 2012 Mar;39(3):669-76. doi: 10.1183/09031936.00051711. Epub 2011 Aug 18.

Reference Type RESULT
PMID: 21852337 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KSH-TCH-IIT-2010-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Early Detection of Lung Cancer
NCT03181256 ACTIVE_NOT_RECRUITING
Nashville Early Diagnosis Lung Cancer Project
NCT01475500 ACTIVE_NOT_RECRUITING